Physician profile
Jack D Summer
NPI 1366514820
$2,145.14
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,726 · 2020: $262 · 2021: $158.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $276.37 | 2019-2020 | |
| Abbvie INC. | $252.05 | 2019-2021 | |
| Lilly USA, LLC | $224.03 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $186.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $165.08 | 2019-2020 | |
| Amarin Pharma, INC. | $126.12 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $105.86 | 2019 | |
| Allergan, INC. | $98.39 | 2019-2020 | |
| Radius Health, INC. | $94.69 | 2019 | |
| Novo Nordisk INC | $69.99 | 2019-2020 | |
| Celgene Corporation | $64.92 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $62.06 | 2019 | |
| Glaxosmithkline, LLC. | $57.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.04 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $41.36 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.79 | 2019 | |
| Ucb, INC. | $37.67 | 2019 | |
| Horizon Therapeutics Plc | $26.52 | 2019 | |
| Mallinckrodt Enterprises LLC | $25.99 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $22.60 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.05 | 2019 | |
| Assertio Therapeutics, INC. | $20.76 | 2019 | |
| Sanofi Pasteur INC. | $19.24 | 2019 | |
| Pfizer INC. | $12.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Summer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.